Literature DB >> 21037325

Non-erythroid effects of erythropoietin.

Murat O Arcasoy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21037325      PMCID: PMC2966898          DOI: 10.3324/haematol.2010.030213

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  20 in total

1.  Cardioprotective effects of recombinant human erythropoietin in rats with experimental autoimmune myocarditis.

Authors:  Wataru Mitsuma; Masahiro Ito; Makoto Kodama; Koichi Fuse; Kazuki Okamura; Shiro Minagawa; Kiminori Kato; Haruo Hanawa; Ken Toba; Mikio Nakazawa; Yoshifusa Aizawa
Journal:  Biochem Biophys Res Commun       Date:  2006-04-19       Impact factor: 3.575

Review 2.  Erythroblastic islands: niches for erythropoiesis.

Authors:  Joel Anne Chasis; Narla Mohandas
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

3.  Macrophages as novel target cells for erythropoietin.

Authors:  Lilach Lifshitz; Galit Tabak; Max Gassmann; Moshe Mittelman; Drorit Neumann
Journal:  Haematologica       Date:  2010-06-30       Impact factor: 9.941

4.  Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models.

Authors:  M Mittelman; D Neumann; A Peled; P Kanter; N Haran-Ghera
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

5.  A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.

Authors:  Moonkyoung Um; Alec W Gross; Harvey F Lodish
Journal:  Cell Signal       Date:  2006-08-30       Impact factor: 4.315

6.  Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?

Authors:  Sara Prutchi-Sagiv; Natalia Golishevsky; Howard S Oster; Odelia Katz; Amos Cohen; Elizabeth Naparstek; Drorit Neumann; Moshe Mittelman
Journal:  Br J Haematol       Date:  2006-12       Impact factor: 6.998

7.  Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.

Authors:  Michael Brines; Giovanni Grasso; Fabio Fiordaliso; Alessandra Sfacteria; Pietro Ghezzi; Maddalena Fratelli; Roberto Latini; Qiao-Wen Xie; John Smart; Chiao-Ju Su-Rick; Eileen Pobre; Deborah Diaz; Daniel Gomez; Carla Hand; Thomas Coleman; Anthony Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-29       Impact factor: 11.205

8.  Enhanced erythro-phagocytosis in polycythemic mice overexpressing erythropoietin.

Authors:  Anna Bogdanova; Deyan Mihov; Hans Lutz; Bianca Saam; Max Gassmann; Johannes Vogel
Journal:  Blood       Date:  2007-03-29       Impact factor: 22.113

9.  Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis.

Authors:  Davide Agnello; Paolo Bigini; Pia Villa; Tiziana Mennini; Anthony Cerami; Michael L Brines; Pietro Ghezzi
Journal:  Brain Res       Date:  2002-10-11       Impact factor: 3.252

10.  Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis.

Authors:  Pia Villa; Paolo Bigini; Tiziana Mennini; Davide Agnello; Teresa Laragione; Alfredo Cagnotto; Barbara Viviani; Marina Marinovich; Anthony Cerami; Thomas R Coleman; Michael Brines; Pietro Ghezzi
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307

View more
  11 in total

1.  Growth factors enhance liver regeneration in acute-on-chronic liver failure.

Authors:  Chandan Kumar Kedarisetty; Lovkesh Anand; Arshi Khanam; Anupam Kumar; Archana Rastogi; Rakhi Maiwall; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2014-05-25       Impact factor: 6.047

Review 2.  Erythropoietin or darbepoetin for patients with cancer.

Authors:  Thomy Tonia; Annette Mettler; Nadège Robert; Guido Schwarzer; Jerome Seidenfeld; Olaf Weingart; Chris Hyde; Andreas Engert; Julia Bohlius
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

3.  Erythropoietin mediated bone formation is regulated by mTOR signaling.

Authors:  Jinkoo Kim; Younghun Jung; Hongli Sun; Jeena Joseph; Anjali Mishra; Yusuke Shiozawa; Jingcheng Wang; Paul H Krebsbach; Russell S Taichman
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

4.  Granulocytes Negatively Regulate Secretion of Transforming Growth Factor β1 by Bone Marrow Mononuclear Cells via Secretion of Erythropoietin Receptors in the Milieu.

Authors:  Vaijayanti Kale
Journal:  Stem Cell Rev Rep       Date:  2021-11-13       Impact factor: 6.692

Review 5.  Robust increases in erythropoietin production by the hypoxic fetus is a response to protect the brain and other vital organs.

Authors:  Kari A Teramo; Miira M Klemetti; John A Widness
Journal:  Pediatr Res       Date:  2018-06-12       Impact factor: 3.756

6.  Erythropoietin produced by genetic-modified NIH/3T3 fibroblasts enhances the survival of degenerating neurons.

Authors:  Yi-Chin Li; Shiu-Jau Chen; Chung-Liang Chien
Journal:  Brain Behav       Date:  2015-06-03       Impact factor: 2.708

7.  Exercise capacity and cardiac hemodynamic response in female ApoE/LDLR(-/-) mice: a paradox of preserved V'O2max and exercise capacity despite coronary atherosclerosis.

Authors:  M Wojewoda; U Tyrankiewicz; P Gwozdz; T Skorka; M Jablonska; A Orzylowska; K Jasinski; A Jasztal; K Przyborowski; R B Kostogrys; J A Zoladz; S Chlopicki
Journal:  Sci Rep       Date:  2016-04-25       Impact factor: 4.379

8.  Biologically active recombinant human erythropoietin expressed in hairy root cultures and regenerated plantlets of Nicotiana tabacum L.

Authors:  Poornima Devi Gurusamy; Holger Schäfer; Siva Ramamoorthy; Michael Wink
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

Review 9.  Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies.

Authors:  José Carlos Rivera; Mari Holm; Dordi Austeng; Tora Sund Morken; Tianwei Ellen Zhou; Alexandra Beaudry-Richard; Estefania Marin Sierra; Olaf Dammann; Sylvain Chemtob
Journal:  J Neuroinflammation       Date:  2017-08-22       Impact factor: 8.322

10.  Increased bone formation in a rabbit long-bone defect model after single local and single systemic application of erythropoietin.

Authors:  Georg W Omlor; Kerstin Kleinschmidt; Simone Gantz; Anja Speicher; Thorsten Guehring; Wiltrud Richter
Journal:  Acta Orthop       Date:  2016-06-27       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.